Related references
Note: Only part of the references are listed.AI-Based Detection, Classification and Prediction/Prognosis in Medical Imaging: Towards Radiophenomics
Fereshteh Yousefirizi et al.
PET CLINICS (2022)
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
Jakoba J. Eertink et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL
Peng Zhao et al.
ANNALS OF NUCLEAR MEDICINE (2021)
Will Baseline Total Lesion Glycolysis Play a Role in Improving the Prognostic Value of the NCCN-IPI in Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated With the R-CHOP Regimen?
Chong Jiang et al.
CLINICAL NUCLEAR MEDICINE (2021)
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?
Manuel Pineiro-Fiel et al.
EUROPEAN RADIOLOGY (2021)
Prognostic Value of Baseline Radiomic Features of 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
Kun-Han Lue et al.
DIAGNOSTICS (2021)
Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach
Yi Zhou et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
A Systematic Review of PET Textural Analysis and Radiomics in Cancer
Manuel Pineiro-Fiel et al.
DIAGNOSTICS (2021)
Radiomics in PET Imaging: A Practical Guide for Newcomers
Fanny Orlhac et al.
PET CLINICS (2021)
Value of total lesion glycolysis and cell-of-origin subtypes for prognostic stratification of diffuse large B-cell lymphoma patients
Chong Jiang et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2021)
Radiomics and Digital Image Texture Analysis in Oncology (Review)
A. A. Litvin et al.
SOVREMENNYE TEHNOLOGII V MEDICINE (2021)
Radiomics of small renal masses on multiphasic CT: accuracy of machine learning-based classification models for the differentiation of renal cell carcinoma and angiomyolipoma without visible fat
Ruimeng Yang et al.
EUROPEAN RADIOLOGY (2020)
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
Laetitia Vercellino et al.
BLOOD (2020)
Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy
Nicolas Aide et al.
EUROPEAN RADIOLOGY (2020)
Development and validation of an 18F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma
Hongxi Wang et al.
EUROPEAN RADIOLOGY (2020)
Value of18F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen
Chong Jiang et al.
ANNALS OF NUCLEAR MEDICINE (2020)
Radiomics in PET/CT: Current Status and Future AI-Based Evolutions
Mathieu Hatt et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI
Qaid Ahmed Shagera et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Differentiation of glioblastoma from solitary brain metastases using radiomic machine-learning classifiers
Zenghui Qian et al.
CANCER LETTERS (2019)
Prognostic Value of Pretreatment Radiomic Features of 18F-FDG PET in Patients With Hodgkin Lymphoma
Kun-Han Lue et al.
CLINICAL NUCLEAR MEDICINE (2019)
Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma
Marius E. Mayerhoefer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Prediction of Overall Survival and Progression-Free Survival by the 18F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma
Yi Zhou et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2019)
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China
Yuankai Shi et al.
CHINESE JOURNAL OF CANCER RESEARCH (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma
Mathieu Nessim Toledano et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Understanding Changes in Tumor Texture Indices in PET: A Comparison Between Visual Assessment and Index Values in Simulated and Patient Data
Fanny Orlhac et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Radiomics: the bridge between medical imaging and personalized medicine
Philippe Lambin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma
Tarec Christoffer El-Galaly et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
Laurie H. Sehn et al.
BLOOD (2015)
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou et al.
BLOOD (2014)
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
Michel Meignan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Gastrointestinal Lymphoma: Recent Advances in Diagnosis and Treatment
Shotaro Nakamura et al.
DIGESTION (2013)
Prognostic value of metabolic tumor volume on PET?/?CT in primary gastrointestinal diffuse large B cell lymphoma
Moo-Kon Song et al.
CANCER SCIENCE (2012)
Radiomics: Extracting more information from medical images using advanced feature analysis
Philippe Lambin et al.
EUROPEAN JOURNAL OF CANCER (2012)
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Jonathan W. Friedberg
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2011)
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era
Marita Ziepert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: A preliminary study
S.-Y. Suh et al.
EUROPEAN JOURNAL OF CANCER (2007)
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
Laurie H. Sehn et al.
BLOOD (2007)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte
P Feugier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
